CRKL Enhances YAP Signaling through Binding and JNK/JUN Pathway Activation in Liver Cancer
Authors:
- Marie C. WesenerMWMarie C. Wesener
- Sofia M. E. WeilerSWSofia M. E. Weiler
- Michaela BissingerMBMichaela Bissinger
- Tobias F. KlessingerTKTobias F. Klessinger
- Fabian RoseFRFabian Rose
- Sabine MerkerSMSabine Merker
- Marcin LuzarowskiMLMarcin Luzarowski
- Thomas RuppertTRThomas Ruppert
- Barbara HelmBHBarbara Helm
- Ursula KlingmüllerUKUrsula Klingmüller
- Peter SchirmacherPSPeter Schirmacher
- Kai BreuhahnKBKai Breuhahn
Open Access
- 5 August 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8549
Abstract
The Hippo pathway transducers yes-associated protein (YAP) and WW-domain containing transcription regulator 1 (WWTR1/TAZ) are key regulators of liver tumorigenesis, promoting tumor formation and progression. Although the first inhibitors are in clinical trials, targeting the relevant upstream regulators of YAP/TAZ activity could prove equally beneficial. To identify regulators of YAP/TAZ activity in hepatocarcinoma (HCC) cells, we carried out a proximity labelling approach (BioID) coupled with mass spectrometry. We verified CRK-like proto-oncogene adaptor protein (CRKL) as a new YAP-exclusive interaction partner. CRKL is highly expressed in HCC patients, and its expression is associated with YAP activity as well as poor survival prognosis. In vitro experiments demonstrated CRKL-dependent cell survival and the loss of YAP binding induced through actin disruption. Moreover, we delineated the activation of the JNK/JUN pathway by CRKL, which promoted YAP transcription. Our data illustrate that CRKL not only promoted YAP activity through its binding but also through the induction of YAP transcription by JNK/JUN activation. This emphasizes the potential use of targeting the JNK/JUN pathway to suppress YAP expression in HCC patients.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (314905040, 031L0256A, 031L0257C, 16LW0234, 82DZL004C4)
- Physician-Scientist Program of Heidelberg University, Faculty of Medicine (314905040, 031L0256A, 031L0257C, 16LW0234, 82DZL004C4)
- German Ministry of Education and Research (BMBF) (314905040, 031L0256A, 031L0257C, 16LW0234, 82DZL004C4)
- German Center for Lung Research (DZL) (314905040, 031L0256A, 031L0257C, 16LW0234, 82DZL004C4)
This publication has 46 references indexed in Scilit:
- Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communicationCellular and Molecular Life Sciences, 2024
- SEPTIN10-mediated crosstalk between cytoskeletal networks controls mechanotransduction and oncogenic YAP/TAZ signalingCancer Letters, 2024
- Src kinase: Key effector in mechanosignallingThe International Journal of Biochemistry & Cell Biology, 2021
- Novel role for CRK adaptor proteins as essential components of SRC/FAK signaling for epithelial–mesenchymal transition and colorectal cancer aggressivenessInternational Journal of Cancer, 2020
- TAZ target gene ITGAV regulates invasion and feeds back positively on YAP and TAZ in liver cancer cellsCancer Letters, 2020
- CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer CellsCell Reports, 2017
- Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic SteatohepatitisCell Metabolism, 2016
- A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing FactorsCell, 2013
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130CasCell, 2006